1. A. V. Amelin, Yu. D. Ignatov, and A. A. Skoromets, Migraine (Pathogenesis, Clinic, Treatment) [in Russian], St. Petersburg (2001).
2. K. L. Dechant and S. P. Clissold, Drugs, 43(5), 776 – 798 (1992).
3. N. E. Gilhus, Migraine: Specific Points and Strategy for Treatment,in: Workshop Treatment of Headache, Statens Legeniddelkontroll, Oslo, Norway, Lakemedeisverket, Uppsala, Sweden, 3 (1994), pp. 69 – 82.
4. P. Karlsberg, H. W. Elliot, and J. E. Adams, Neurology, 13, 772 – 778 (1963).
5. R. S. Mirzoyan, T. S. Ganshina, and N. A. Romanytcheva, Individual differences in antiserotonin cerebrovascular effects of propranolol and tolfenamic acid, in: Biological Basis of Individual Sensitivity to Psychotropic Drugs, S. B. Seredenin, V. Longo, and G. Gaviraghi (eds.), Graffman Press Ltd. (1994), pp. 121 – 125.